Radiofrequency global endometrial ablation followed by hysteroscopic sterilization

Matthew R. Hopkins, Douglas J. Creedon, Sherif A. El-Nashar, Douglas L. Brown, Andrew E. Good, Abimbola O. Famuyide

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Study objective: To describe the feasibility of performing Essure hysteroscopic sterilization immediately after NovaSure global endometrial ablation (GEA). Design: Descriptive feasibility study (Canadian Task Force classification III). Setting: Midwestern United States academic medical center. Patients: Twenty-five women (aged 35-49 years) with menorrhagia who elected GEA treatment and requested concurrent permanent sterilization. Interventions: NovaSure GEA followed immediately by Essure hysteroscopic sterilization. Patients returned 3 months after the procedure for hysterosalpingography (HSG) to document tubal occlusion. Measurements and main results: The inserts were placed successfully in all 25 patients; 21 returned for 3-month follow-up HSG, as recommended. Bilateral tubal occlusion was documented at 3 months in 19 patients (90%) and unilateral occlusion in 2 patients. Six-month postprocedural HSG in these 2 patients documented bilateral tubal occlusion. Hysterosalpingography was not performed in 4 patients. In all 21 patients with appropriate follow-up, complete occlusion was documented, and the ability to perform or interpret HSG was not affected by endometrial ablation. Conclusion: Essure hysteroscopic sterilization can be safely performed after NovaSure GEA. Intrauterine synechiae do not appear to adversely affect the ability to perform HSG at 3 months or to document tubal occlusion.

Original languageEnglish (US)
Pages (from-to)494-501
Number of pages8
JournalJournal of Minimally Invasive Gynecology
Volume14
Issue number4
DOIs
StatePublished - Jul 2007

Fingerprint

Endometrial Ablation Techniques
Hysterosalpingography
Tubal Sterilization
Gynatresia
Midwestern United States
Menorrhagia
Feasibility Studies
Advisory Committees

Keywords

  • Endometrial ablation
  • Hysteroscopic
  • Menorrhagia
  • Sterilization

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Hopkins, M. R., Creedon, D. J., El-Nashar, S. A., Brown, D. L., Good, A. E., & Famuyide, A. O. (2007). Radiofrequency global endometrial ablation followed by hysteroscopic sterilization. Journal of Minimally Invasive Gynecology, 14(4), 494-501. https://doi.org/10.1016/j.jmig.2007.01.014

Radiofrequency global endometrial ablation followed by hysteroscopic sterilization. / Hopkins, Matthew R.; Creedon, Douglas J.; El-Nashar, Sherif A.; Brown, Douglas L.; Good, Andrew E.; Famuyide, Abimbola O.

In: Journal of Minimally Invasive Gynecology, Vol. 14, No. 4, 07.2007, p. 494-501.

Research output: Contribution to journalArticle

Hopkins, MR, Creedon, DJ, El-Nashar, SA, Brown, DL, Good, AE & Famuyide, AO 2007, 'Radiofrequency global endometrial ablation followed by hysteroscopic sterilization', Journal of Minimally Invasive Gynecology, vol. 14, no. 4, pp. 494-501. https://doi.org/10.1016/j.jmig.2007.01.014
Hopkins, Matthew R. ; Creedon, Douglas J. ; El-Nashar, Sherif A. ; Brown, Douglas L. ; Good, Andrew E. ; Famuyide, Abimbola O. / Radiofrequency global endometrial ablation followed by hysteroscopic sterilization. In: Journal of Minimally Invasive Gynecology. 2007 ; Vol. 14, No. 4. pp. 494-501.
@article{d8c46a5491c54a02a27d5999450cd59f,
title = "Radiofrequency global endometrial ablation followed by hysteroscopic sterilization",
abstract = "Study objective: To describe the feasibility of performing Essure hysteroscopic sterilization immediately after NovaSure global endometrial ablation (GEA). Design: Descriptive feasibility study (Canadian Task Force classification III). Setting: Midwestern United States academic medical center. Patients: Twenty-five women (aged 35-49 years) with menorrhagia who elected GEA treatment and requested concurrent permanent sterilization. Interventions: NovaSure GEA followed immediately by Essure hysteroscopic sterilization. Patients returned 3 months after the procedure for hysterosalpingography (HSG) to document tubal occlusion. Measurements and main results: The inserts were placed successfully in all 25 patients; 21 returned for 3-month follow-up HSG, as recommended. Bilateral tubal occlusion was documented at 3 months in 19 patients (90{\%}) and unilateral occlusion in 2 patients. Six-month postprocedural HSG in these 2 patients documented bilateral tubal occlusion. Hysterosalpingography was not performed in 4 patients. In all 21 patients with appropriate follow-up, complete occlusion was documented, and the ability to perform or interpret HSG was not affected by endometrial ablation. Conclusion: Essure hysteroscopic sterilization can be safely performed after NovaSure GEA. Intrauterine synechiae do not appear to adversely affect the ability to perform HSG at 3 months or to document tubal occlusion.",
keywords = "Endometrial ablation, Hysteroscopic, Menorrhagia, Sterilization",
author = "Hopkins, {Matthew R.} and Creedon, {Douglas J.} and El-Nashar, {Sherif A.} and Brown, {Douglas L.} and Good, {Andrew E.} and Famuyide, {Abimbola O.}",
year = "2007",
month = "7",
doi = "10.1016/j.jmig.2007.01.014",
language = "English (US)",
volume = "14",
pages = "494--501",
journal = "Journal of Minimally Invasive Gynecology",
issn = "1553-4650",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Radiofrequency global endometrial ablation followed by hysteroscopic sterilization

AU - Hopkins, Matthew R.

AU - Creedon, Douglas J.

AU - El-Nashar, Sherif A.

AU - Brown, Douglas L.

AU - Good, Andrew E.

AU - Famuyide, Abimbola O.

PY - 2007/7

Y1 - 2007/7

N2 - Study objective: To describe the feasibility of performing Essure hysteroscopic sterilization immediately after NovaSure global endometrial ablation (GEA). Design: Descriptive feasibility study (Canadian Task Force classification III). Setting: Midwestern United States academic medical center. Patients: Twenty-five women (aged 35-49 years) with menorrhagia who elected GEA treatment and requested concurrent permanent sterilization. Interventions: NovaSure GEA followed immediately by Essure hysteroscopic sterilization. Patients returned 3 months after the procedure for hysterosalpingography (HSG) to document tubal occlusion. Measurements and main results: The inserts were placed successfully in all 25 patients; 21 returned for 3-month follow-up HSG, as recommended. Bilateral tubal occlusion was documented at 3 months in 19 patients (90%) and unilateral occlusion in 2 patients. Six-month postprocedural HSG in these 2 patients documented bilateral tubal occlusion. Hysterosalpingography was not performed in 4 patients. In all 21 patients with appropriate follow-up, complete occlusion was documented, and the ability to perform or interpret HSG was not affected by endometrial ablation. Conclusion: Essure hysteroscopic sterilization can be safely performed after NovaSure GEA. Intrauterine synechiae do not appear to adversely affect the ability to perform HSG at 3 months or to document tubal occlusion.

AB - Study objective: To describe the feasibility of performing Essure hysteroscopic sterilization immediately after NovaSure global endometrial ablation (GEA). Design: Descriptive feasibility study (Canadian Task Force classification III). Setting: Midwestern United States academic medical center. Patients: Twenty-five women (aged 35-49 years) with menorrhagia who elected GEA treatment and requested concurrent permanent sterilization. Interventions: NovaSure GEA followed immediately by Essure hysteroscopic sterilization. Patients returned 3 months after the procedure for hysterosalpingography (HSG) to document tubal occlusion. Measurements and main results: The inserts were placed successfully in all 25 patients; 21 returned for 3-month follow-up HSG, as recommended. Bilateral tubal occlusion was documented at 3 months in 19 patients (90%) and unilateral occlusion in 2 patients. Six-month postprocedural HSG in these 2 patients documented bilateral tubal occlusion. Hysterosalpingography was not performed in 4 patients. In all 21 patients with appropriate follow-up, complete occlusion was documented, and the ability to perform or interpret HSG was not affected by endometrial ablation. Conclusion: Essure hysteroscopic sterilization can be safely performed after NovaSure GEA. Intrauterine synechiae do not appear to adversely affect the ability to perform HSG at 3 months or to document tubal occlusion.

KW - Endometrial ablation

KW - Hysteroscopic

KW - Menorrhagia

KW - Sterilization

UR - http://www.scopus.com/inward/record.url?scp=34447265955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447265955&partnerID=8YFLogxK

U2 - 10.1016/j.jmig.2007.01.014

DO - 10.1016/j.jmig.2007.01.014

M3 - Article

VL - 14

SP - 494

EP - 501

JO - Journal of Minimally Invasive Gynecology

JF - Journal of Minimally Invasive Gynecology

SN - 1553-4650

IS - 4

ER -